Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection

Key Takeaway: Ignite Proteomics has announced the establishment of a prospective oncology registry aimed at evaluating functional proteomics for cancer therapy selection. The registry is expected to involve 10,000 patients, although specific details on the implementation and expected outcomes are not provided in the article.